Variant report
Variant | nsv969591 |
---|---|
Chromosome Location | chr9:44064300-44070279 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:48)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:48 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr9:44065378-44065708 | GM12878 | blood: | n/a | n/a |
2 | BATF | chr9:44065395-44065684 | GM12878 | blood: | n/a | n/a |
3 | CEBPD | chr9:44065597-44065994 | K562 | blood: | n/a | n/a |
4 | EP300 | chr9:44068552-44068791 | GM12878 | blood: | n/a | n/a |
5 | FOSL2 | chr9:44065696-44066071 | HepG2 | liver: | n/a | n/a |
6 | FOSL2 | chr9:44065721-44066055 | HepG2 | liver: | n/a | n/a |
7 | FOXA1 | chr9:44068413-44068889 | HepG2 | liver: | n/a | chr9:44068780-44068792 |
8 | GATA2 | chr9:44070239-44070893 | K562 | blood: | n/a | chr9:44070292-44070299 chr9:44070288-44070304 chr9:44070292-44070299 chr9:44070285-44070306 chr9:44070292-44070299 |
9 | GATA2 | chr9:44065418-44066111 | K562 | blood: | n/a | n/a |
10 | GATA2 | chr9:44068461-44068795 | K562 | blood: | n/a | chr9:44068607-44068618 |
11 | GATA2 | chr9:44066829-44067076 | K562 | blood: | n/a | n/a |
12 | HEY1 | chr9:44065778-44066092 | K562 | blood: | n/a | n/a |
13 | HEY1 | chr9:44065636-44066095 | HepG2 | liver: | n/a | n/a |
14 | IRF4 | chr9:44064074-44064431 | GM12878 | blood: | n/a | n/a |
15 | JUND | chr9:44065718-44066047 | HepG2 | liver: | n/a | n/a |
16 | JUND | chr9:44065802-44065943 | HepG2 | liver: | n/a | n/a |
17 | JUND | chr9:44068149-44068378 | HepG2 | liver: | n/a | n/a |
18 | MAFK | chr9:44064377-44064540 | HepG2 | liver: | n/a | chr9:44064431-44064448 |
19 | PAX5 | chr9:44065710-44065964 | GM12878 | blood: | n/a | n/a |
20 | PAX5 | chr9:44068124-44068299 | GM12878 | blood: | n/a | n/a |
21 | PAX5 | chr9:44064073-44064363 | GM12878 | blood: | n/a | n/a |
22 | POLR2A | chr9:44065765-44066055 | H1-hESC | embryonic stem cell: | n/a | n/a |
23 | POLR2A | chr9:44065794-44066021 | HepG2 | liver: | n/a | n/a |
24 | POU2F2 | chr9:44066016-44066434 | GM12878 | blood: | n/a | n/a |
25 | POU2F2 | chr9:44068043-44068387 | GM12878 | blood: | n/a | chr9:44068359-44068371 |
26 | RXRA | chr9:44063841-44064436 | HepG2 | liver: | n/a | n/a |
27 | RXRA | chr9:44068118-44068312 | HepG2 | liver: | n/a | n/a |
28 | RXRA | chr9:44065756-44065944 | HepG2 | liver: | n/a | n/a |
29 | RXRA | chr9:44065645-44066156 | HepG2 | liver: | n/a | n/a |
30 | SIN3AK20 | chr9:44065770-44065941 | HepG2 | liver: | n/a | n/a |
31 | SIN3AK20 | chr9:44069016-44069185 | HepG2 | liver: | n/a | n/a |
32 | SIX5 | chr9:44065947-44066270 | K562 | blood: | n/a | n/a |
33 | SP1 | chr9:44066102-44066368 | GM12878 | blood: | n/a | n/a |
34 | SP1 | chr9:44068531-44068855 | GM12878 | blood: | n/a | chr9:44068617-44068624 |
35 | SP1 | chr9:44065675-44066324 | HepG2 | liver: | n/a | n/a |
36 | SP1 | chr9:44065256-44065731 | GM12878 | blood: | n/a | n/a |
37 | SPI1 | chr9:44065716-44066029 | K562 | blood: | n/a | n/a |
38 | SPI1 | chr9:44064125-44064330 | K562 | blood: | n/a | n/a |
39 | SPI1 | chr9:44065305-44065443 | K562 | blood: | n/a | n/a |
40 | SPI1 | chr9:44064130-44064383 | GM12878 | blood: | n/a | n/a |
41 | STAT5A | chr9:44065542-44065980 | K562 | blood: | n/a | n/a |
42 | TCF12 | chr9:44065987-44066213 | GM12878 | blood: | n/a | n/a |
43 | TCF12 | chr9:44066396-44066604 | HepG2 | liver: | n/a | n/a |
44 | USF1 | chr9:44065821-44065998 | HepG2 | liver: | n/a | n/a |
45 | USF1 | chr9:44065820-44065947 | HepG2 | liver: | n/a | n/a |
46 | USF1 | chr9:44069515-44069619 | HepG2 | liver: | n/a | n/a |
47 | ZBTB33 | chr9:44065721-44066024 | GM12878 | blood: | n/a | n/a |
48 | ZBTB33 | chr9:44068423-44068772 | HepG2 | liver: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000170165 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559752825 | chr9:44064317-44064318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs368012750 | chr9:44064331-44064332 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548568672 | chr9:44064370-44064371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs570388286 | chr9:44064387-44064388 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs62536313 | chr9:44064451-44064452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs140279206 | chr9:44064487-44064488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs62536314 | chr9:44064539-44064540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs535171769 | chr9:44064571-44064572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs553592467 | chr9:44064595-44064596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs553254844 | chr9:44064604-44064605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs189234215 | chr9:44064636-44064637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs535863735 | chr9:44064655-44064656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs541797293 | chr9:44064666-44064667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs554122530 | chr9:44064682-44064683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs575965727 | chr9:44064684-44064685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs145374793 | chr9:44064709-44064710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs146484090 | chr9:44064710-44064711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs62536315 | chr9:44064717-44064718 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs185473183 | chr9:44064720-44064721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs564252468 | chr9:44064731-44064732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs530193387 | chr9:44064753-44064754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs533303282 | chr9:44064770-44064771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs71512050 | chr9:44064856-44064857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs563659959 | chr9:44064874-44064875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs114045364 | chr9:44064892-44064893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552596811 | chr9:44064943-44064944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs374867312 | chr9:44064979-44064980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs571083593 | chr9:44065018-44065019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs369354978 | chr9:44065048-44065049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs62536316 | chr9:44065095-44065096 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
31 | rs547140110 | chr9:44065113-44065114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs565465541 | chr9:44065122-44065123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs190085486 | chr9:44065141-44065142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs547822408 | chr9:44065144-44065145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs569305596 | chr9:44065162-44065163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs375646897 | chr9:44065171-44065172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183017600 | chr9:44065178-44065179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs558587233 | chr9:44065211-44065212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs577033075 | chr9:44065232-44065233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs202029178 | chr9:44065252-44065253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs534538717 | chr9:44065306-44065307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553185461 | chr9:44065350-44065351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs373345914 | chr9:44065372-44065373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs112611277 | chr9:44065383-44065384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs377499191 | chr9:44065450-44065451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs542336004 | chr9:44065473-44065474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs186694088 | chr9:44065477-44065478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs575716710 | chr9:44065494-44065495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs546142842 | chr9:44065498-44065499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs79083017 | chr9:44065499-44065500 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 22183965 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Oral cancer | 21386901 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Sezary syndrome | 18413736 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Schizophrenia | 21346763 | CNVD |
Breast cancer | 21990379 | CNVD |
Astrocytoma | 22246337 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Lung cancer | 17086460 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Schizophrenia | 20967226 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:44057200-44070600 | Weak transcription | Liver | Liver |
2 | chr9:44070200-44070600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |